ClinConnect ClinConnect Logo
Search / Trial NCT04777305

The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients

Launched by TEL AVIV UNIVERSITY · Feb 25, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Obesity Bariatric Surgery Muscle Mass Loss Exercise Training

ClinConnect Summary

The POWER BARIATRIC Trial is a research study focused on understanding how different types of exercise can help people who are severely obese, especially after they have undergone bariatric surgery. The trial will compare three exercise programs: one focused on aerobic activities (like walking or cycling), one on resistance training (like lifting weights), and a combined program that includes both types. The goal is to see how these exercises can prevent muscle loss and help reduce body fat, as well as how they affect overall health, including heart and metabolic markers, after surgery.

To participate, individuals must be between 18 and 65 years old and currently do little to no exercise (less than one hour a week) while being candidates for bariatric surgery. Those with certain health issues or past surgeries are not eligible. Participants will be randomly assigned to one of the exercise programs or a standard care group and will be monitored over six months. They will undergo various health assessments, including body composition tests and physical performance evaluations, to track their progress and the study's effects. This trial aims to improve post-surgery recovery and overall health for people battling obesity.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Sedentary participants: regular exercise performed \<1 hour per week
  • Candidates for primary bariatric surgery at Herzliya Medical Center in accordance to the National Institutes of Health (NIH) criteria for surgery: (body mass index (BMI) \> 40 without coexisting co-morbidities or BMI \> 35 with \> 1 severe obesity-related comorbidities)
  • Sex: all
  • Age: 18 to 65 years.
  • Exclusion Criteria:
  • Severe cardiopulmonary disease (e.g., recent myocardial infarction or unstable angina)
  • Musculoskeletal or neuromuscular impairments that preclude exercise training
  • Cognitive impairments
  • Use of drugs that affect bone or muscle metabolism (mainly steroids)
  • Patients with previous bariatric surgery

About Tel Aviv University

Tel Aviv University (TAU) is a leading research institution in Israel, renowned for its commitment to advancing knowledge and innovation across various fields, including medicine and biomedical research. With a strong emphasis on interdisciplinary collaboration, TAU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and developing novel therapeutic strategies. The university's robust network of researchers, state-of-the-art facilities, and partnerships with healthcare organizations enable it to contribute significantly to the global medical research community, fostering advancements that address critical health challenges.

Locations

Tel Aviv, Other, Israel

Patients applied

0 patients applied

Trial Officials

Yftach Gepner, Ph.D.

Principal Investigator

Tel Aviv University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials